Therefore, the high mutation rate of ADGRG6 enhancer hotspot mutations in bladder cancer patients in this study was attributed to the high sensitivity of the ARMS‐qPCR assay and the fact that urine allows for the better tumor information collection. This evidence concerns the gene ADGRG6 and urinary bladder cancer.